Financial Instruments - Narrative (Details) - USD ($) $ in Thousands		12 Months Ended
		Jun. 30, 2024	Jun. 25, 2023	Jun. 26, 2022
Financial Instruments [Line Items]
Financial instruments		$ 5,847,856	$ 5,337,056
Restricted cash and cash equivalents	[1]	$ 2,947	$ 250,316	$ 251,534
Accounts Receivable | Customer Concentration Risk | Customer 1
Financial Instruments [Line Items]
Concentration by percent		16.00%	32.00%
Accounts Receivable | Customer Concentration Risk | Customer 2
Financial Instruments [Line Items]
Concentration by percent		13.00%	13.00%
Accounts Receivable | Customer Concentration Risk | Customer 3
Financial Instruments [Line Items]
Concentration by percent		13.00%	10.00%
Foreign Exchange Contracts | Forward Contracts | Buy Contracts | Designated for Hedge Accounting Treatment
Financial Instruments [Line Items]
Notional value		$ 307,300
Foreign Exchange Contracts | Forward Contracts | Buy Contracts | Not Designated for Hedge Accounting Treatment
Financial Instruments [Line Items]
Notional value		366,900
Foreign Exchange Contracts | Forward Contracts | Sell Contracts | Designated for Hedge Accounting Treatment
Financial Instruments [Line Items]
Notional value		136,500
Foreign Exchange Contracts | Forward Contracts | Sell Contracts | Not Designated for Hedge Accounting Treatment
Financial Instruments [Line Items]
Notional value		$ 238,200
Cash Flow Hedging
Financial Instruments [Line Items]
Reclassification from other comprehensive income to earnings, period		12 months
Cash Flow Hedging | Minimum
Financial Instruments [Line Items]
Foreign currency forward contract, expiration period		12 months
Cash Flow Hedging | Maximum
Financial Instruments [Line Items]
Foreign currency forward contract, expiration period		24 months
Time Deposits
Financial Instruments [Line Items]
Financial instruments		$ 1,736,079	$ 980,892
Restricted cash and cash equivalents			$ 250,000

[1] Restricted cash is reported within Other assets in the Consolidated Balance Sheets